Two Sigma Investments’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-308,825
| Closed | -$704K | – | 3407 |
|
|
2024
Q2 | $704K | Sell |
308,825
-25,306
| -8% | -$96.7K | ﹤0.01% | 2191 |
|
|
2024
Q1 | $1.44M | Buy |
334,131
+172,068
| +106% | +$600K | ﹤0.01% | 1726 |
|
|
2023
Q4 | $494K | Buy |
162,063
+71,663
| +79% | +$135K | ﹤0.01% | 2466 |
|
|
2023
Q3 | $130K | Buy |
+90,400
| New | +$175K | ﹤0.01% | 2715 |
|
|
2023
Q2 | – | Sell |
-103,783
| Closed | -$278K | – | 3349 |
|
|
2023
Q1 | $278K | Sell |
103,783
-299,520
| -74% | -$1.44M | ﹤0.01% | 2452 |
|
|
2022
Q4 | $2.19M | Buy |
403,303
+141,121
| +54% | +$1.18M | 0.01% | 1290 |
|
|
2022
Q3 | $3.27M | Buy |
262,182
+150,250
| +134% | +$1.72M | 0.01% | 939 |
|
|
2022
Q2 | $553K | Buy |
111,932
+88,047
| +369% | +$488K | ﹤0.01% | 1790 |
|
|
2022
Q1 | $182K | Sell |
23,885
-112,350
| -82% | -$1.07M | ﹤0.01% | 2352 |
|
|
2021
Q4 | $1.39M | Buy |
136,235
+51,504
| +61% | +$656K | ﹤0.01% | 2262 |
|
|
2021
Q3 | $1.14M | Sell |
84,731
-541,023
| -86% | -$8.82M | ﹤0.01% | 2500 |
|
|
2021
Q2 | $13.7M | Sell |
625,754
-211,522
| -25% | -$4.7M | 0.03% | 642 |
|
|
2021
Q1 | $20.1M | Buy |
837,276
+554,801
| +196% | +$12.9M | 0.05% | 430 |
|
|
2020
Q4 | $5.08M | Buy |
282,475
+119,165
| +73% | +$1.78M | 0.01% | 921 |
|
|
2020
Q3 | $1.89M | Buy |
+163,310
| New | +$2.7M | 0.01% | 1328 |
|
|
2020
Q2 | – | Sell |
-121,049
| Closed | -$1.33M | – | 3643 |
|
|
2020
Q1 | $1.33M | Buy |
121,049
+54,178
| +81% | +$1.01M | 0.01% | 1217 |
|
|
2019
Q4 | $1.77M | Buy |
66,871
+55,491
| +488% | +$1.3M | 0.01% | 1691 |
|
|
2019
Q3 | $259K | Buy |
+11,380
| New | +$359K | ﹤0.01% | 3045 |
|
|
2019
Q2 | – | Sell |
-129,420
| Closed | -$2.15M | – | 3749 |
|
|
2019
Q1 | $2.15M | Buy |
129,420
+53,563
| +71% | +$1.02M | 0.01% | 1381 |
|
|
2018
Q4 | $1.45M | Buy |
+75,857
| New | +$2.84M | 0.01% | 1420 |
|
|
2018
Q2 | – | Sell |
-42,305
| Closed | -$1.57M | – | 3742 |
|
|
2018
Q1 | $1.57M | Buy |
42,305
+17,432
| +70% | +$465K | 0.01% | 1696 |
|
|
2017
Q4 | $493K | Buy |
+24,873
| New | +$535K | ﹤0.01% | 2445 |
|
Two Sigma Investments's GTHX Position: Q3 2024 in Review
Two Sigma Investments sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 308,825 shares — an estimated $704K sold.
Two Sigma Investments first reported a position in GTHX in Q4 2017 and held it in 22 quarters. The position peaked at $20.1M in Q1 2021. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.
- Two Sigma Investments reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Two Sigma Investments sold 308,825 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $704K.
- Two Sigma Investments first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2017 and held it in 22 quarters.
- Two Sigma Investments's G1 Therapeutics, Inc. Common Stock position peaked at $20.1M in Q1 2021.
- 0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.
Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.